Immunocore Holdings plc (FRA:6YG)
Germany · Delayed Price · Currency is EUR 27.60
-0.40 (-1.43%)
At close: Feb 20, 2026
Immunocore Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 379.59 | 310.2 | 249.43 | 174.36 | 36.48 | 41.11 |
Revenue | 379.59 | 310.2 | 249.43 | 174.36 | 36.48 | 41.11 |
Revenue Growth (YoY) | 28.11% | 24.37% | 43.05% | 377.91% | -11.26% | 20.94% |
Cost of Revenue | 45.23 | 10.5 | 7.5 | 6.4 | 100.25 | 102.14 |
Gross Profit | 334.36 | 299.7 | 241.92 | 167.96 | -63.76 | -61.02 |
Selling, General & Admin | 165.09 | 155.78 | 144.5 | 123.06 | 110.82 | 62.45 |
Research & Development | 214.38 | 214.38 | 157.08 | 96.61 | - | - |
Other Operating Expenses | -18.05 | -18.05 | 0.9 | -0.01 | 0.07 | -2.19 |
Operating Expenses | 361.42 | 352.11 | 302.47 | 219.66 | 110.9 | 60.26 |
Operating Income | -27.06 | -52.41 | -60.55 | -51.7 | -174.66 | -121.28 |
Interest Expense | -16.15 | -18.84 | -5.15 | -5.41 | -5.57 | -4.24 |
Interest & Investment Income | 17.74 | 25.62 | 17.99 | 3.76 | 0.07 | 0.96 |
Currency Exchange Gain (Loss) | -0.82 | -3.45 | -13.18 | 14.16 | 0.29 | - |
Other Non Operating Income (Expenses) | 2.02 | - | - | - | - | 1.69 |
EBT Excluding Unusual Items | -24.27 | -49.08 | -60.89 | -39.2 | -179.88 | -122.87 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -1.45 |
Other Unusual Items | -3.85 | -3.85 | - | -1.69 | - | 5.05 |
Pretax Income | -28.13 | -52.94 | -60.89 | -40.88 | -179.88 | -119.27 |
Income Tax Expense | 1.1 | -1.85 | -5.6 | 11.66 | 0.15 | -18.11 |
Net Income | -29.23 | -51.09 | -55.29 | -52.54 | -180.03 | -101.16 |
Net Income to Common | -29.23 | -51.09 | -55.29 | -52.54 | -180.03 | -101.16 |
Shares Outstanding (Basic) | 50 | 50 | 49 | 46 | 42 | 27 |
Shares Outstanding (Diluted) | 50 | 50 | 49 | 46 | 42 | 27 |
Shares Change (YoY) | 0.69% | 2.25% | 6.94% | 7.59% | 60.19% | 18.95% |
EPS (Basic) | -0.58 | -1.02 | -1.13 | -1.15 | -4.24 | -3.81 |
EPS (Diluted) | -0.58 | -1.02 | -1.13 | -1.15 | -4.24 | -3.81 |
Free Cash Flow | 2.95 | 20.89 | -2.49 | -51.41 | -144.49 | -87.82 |
Free Cash Flow Per Share | 0.06 | 0.42 | -0.05 | -1.13 | -3.40 | -3.31 |
Gross Margin | 88.08% | 96.61% | 96.99% | 96.33% | -174.77% | -148.42% |
Operating Margin | -7.13% | -16.89% | -24.27% | -29.65% | -478.73% | -294.98% |
Profit Margin | -7.70% | -16.47% | -22.17% | -30.14% | -493.45% | -246.04% |
Free Cash Flow Margin | 0.78% | 6.73% | -1.00% | -29.49% | -396.04% | -213.60% |
EBITDA | -23.47 | -48.21 | -56.46 | -46.37 | -167.07 | -112.48 |
EBITDA Margin | -6.18% | -15.54% | -22.63% | -26.59% | - | -273.57% |
D&A For EBITDA | 3.6 | 4.2 | 4.09 | 5.34 | 7.59 | 8.8 |
EBIT | -27.06 | -52.41 | -60.55 | -51.7 | -174.66 | -121.28 |
EBIT Margin | -7.13% | -16.89% | -24.27% | -29.65% | - | -294.98% |
Revenue as Reported | 379.59 | 310.2 | 249.43 | 174.36 | 36.48 | 41.11 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.